GlassScriptPhysician profile
Miriam Hernandez
NPI 1144594367
$5,716.38
in general payments reported to CMS, 2019-2025
44 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $935 · 2022: $1,382 · 2023: $676 · 2024: $1,232 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,398.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,010.54 | 2021-2025 | |
| Lilly USA, LLC | $701.38 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $567.13 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $549.58 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $430.11 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $253.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.89 | 2021-2023 | Trintellix |
| Novo Nordisk INC | $154.43 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.39 | 2021-2024 | Synjardy, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $139.23 | 2021-2025 | |
| Amgen INC. | $116.35 | 2023-2025 | Otezla, Repatha, Repatha |
| Exact Sciences Corporation | $105.94 | 2023-2025 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $104.76 | 2022-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $101.76 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.60 | 2022-2025 | Xifaxan |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miriam Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.